Lamotrigine Monotherapy in Pediatric Bipolar Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Bipolar Disorder
Interventions
DRUG

Lamotrigine

"It is a mood stabilizer that is clinically the first choice if patients present with depression and is effective in adults for mania in maintenance phase. So it is administered to see how effective it is in children and adolescents.~The dose of lamotrigine will be 12.5 mg per day beginning the first day. It is increased in 12.5 mg increments every week until it reaches 50 mg and 25 mg per week of increment thereafter until maximum dose of 150 mg in those below 50 kg and 200-400 mg depending on clinical response in those above 50 kg."

Trial Locations (1)

60612

NPI, University of Illinois at Chicago, Chicago

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Illinois at Chicago

OTHER